Should You Buy SpaceX Stock on the Dip? Here's My Honest Take.

SpaceX debuted as a public company at roughly a $1.8 trillion IPO valuation and has since pulled back moderately from its post-listing peak. The article argues the business remains strong — citing Starlink, launch leadership, and xAI deals — but says the stock is still not attractive at current levels, with Morningstar estimating fair value at $63 per share versus a market cap of about $830 billion. The author favors waiting for a better entry point, potentially after lockups expire and insider selling begins.

Analysis

The interesting edge here is not “is the business good?” but whether the stock has entered a mechanically fragile phase where price discovery is being dominated by float scarcity, index inclusion, and narrative momentum rather than incremental fundamentals. That setup can persist for weeks, but once lockup supply becomes visible, marginal buyers usually weaken faster than the business thesis deteriorates. In other words, the near-term trade is more about distribution risk than operating risk.

Second-order beneficiaries are the assets that let investors express the same theme without paying full private-market-style multiples. GOOGL should keep benefiting indirectly if AI compute demand remains strong, because any credible capacity provider narrative supports cloud/AI capex expectations; NDAQ is more interesting on the other side, since high-profile inclusion-driven dislocations invite scrutiny around index mechanics and may create a short-term perception overhang for market infrastructure names tied to listings and passive flows. MORN is a quiet winner if investors continue to lean on third-party fair value framing, since valuation discipline becomes more valuable when the market is disconnected from fundamentals.

The contrarian point is that calling the stock overvalued is not the same as calling it shortable. Scarce free float plus “must-own” sentiment can keep implied volatility elevated and make outright shorts structurally expensive until supply unlocks. The better expression is to wait for the lockup window and insider selling, where the supply/demand equation can finally reprice the stock without relying on a business miss; that is a months, not days, catalyst.

If the stock keeps levitating into unlocks, the risk is not collapse but a slow multiple compression as incremental capital rotates to better risk/reward names. If AI commercialization or launch cadence disappoints, the downside can accelerate quickly because the current premium leaves little room for execution slippage.

Key Decisions for Investors

• Avoid initiating outright long exposure in the next 2-4 weeks; wait for post-lockup supply to create a better entry point or a cleaner short setup.
• For investors wanting exposure to the same AI infrastructure theme, prefer a long GOOGL position over chasing the newly listed name; upside is more tied to fundamentals and less dependent on float dynamics.
• Consider a tactical short or put spread in the newly listed stock only into the lockup-expiry window over the next 1-3 months, sized modestly because squeeze risk remains high while float is restricted.
• Use MORN as a relative-value long against the market’s valuation excess: long MORN / short the speculative high-multiple basket if you want to express a valuation-discipline trade over the next quarter.
• If maintaining exposure, prefer call spreads rather than stock: limited premium outlay captures momentum continuation while capping risk if the post-IPO enthusiasm fades abruptly.